Spero Therapeutics, Inc. (SPRO)

2.42 +0.12 (+5.22%) USD  |  NASDAQ  |  Feb 06, 16:00
2.395 -0.02 (-1.03%) After-Hours: 20:00
More

Spero Therapeutics Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for SPRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Cassava Sciences, Inc. Upgrade
Omeros Corp. Upgrade
GeoVax Labs, Inc. Upgrade